“Attention Suppliers!: This is What Keeps Me Up at Night – How Rx-360 Helps (Me Sleep Better)” 

Session Overview

The Worldwide Pharmaceutical Supply Chain, from raw materials to final products on the shelf, continues to face threats as a result of counterfeiting, adulteration, theft, and diversion which reduce the safety and efficacy of the drugs in the consumer’s medicine cabinet.  The severity of the problem was shown when at least 81 people died in 2008 as a result of purposely adulterated Heparin from a plant in China.

This hard-hitting panel, will discuss what these risks to the supply chain are, the severity of the problem, and steps being taken as a result of recent legislation, by regulators and industry to mitigate these risks.  This panel will feature senior leaders from pharma and biotech procurement, and will be directly aimed at Suppliers from the perspective of these professionals.  The panel will focus on the issues of most concern to senior procurement professionals, specifically as it relates to their vendors, and how the activities of Rx-360 and active involvement in the organization by both pharma companies and their suppliers can mitigate these risks.  The Rx-360 consortium will be described and its activities will be discussed by the panel.

The session will be interactive and provide opportunities for the audience to become involved and to ask questions.

Session Goals

As a result of the symposium, the attendee will have a broader and more comprehensive understanding of the risks facing the pharmaceutical supply chain, the concerns of senior procurement professionals with respect to their vendors, the progress that has been made to secure the pharmaceutical supply chain (both from the corporate and government/legislative view) and will have a greater understanding and familiarity and understanding of Rx-360.

Session Panelists

Kim Cauchy
Mylan, Vice President, Global Sourcing

Kim Cauchy is Vice President of Global Sourcing for Mylan and has global responsibility for strategic sourcing and procurement of active pharmaceutical ingredients.  Previous to working at Mylan, Kim held director level global sourcing roles at Hospira and Perrigo.  Prior to his over twenty years of procurement experience, he held various roles within the quality department at Perrigo and was a certified quality auditor.  He holds a BS degree in Pharmaceutical Services from Nazareth College.  He is a two time past board member of the Drug, Chemical and Associated Technologies Association.

Tom Beil
Sigma-Aldrich/SAFC
Vice President
Quality & Regulatory Affairs

Tom Beil is VP of Quality and Regulatory Affairs for Sigma-Aldrich/SAFC. Responsible for leading Sigma-Aldrich/SAFC corporate-wide quality assurance and regulatory programs, Tom re-joined Sigma-Aldrich from the Centocor division of Johnson & Johnson, where he was the Senior Director of Site Quality Assurance.

Prior to working for Centocor, Tom worked as Associate Director of Quality Assurance for Wyeth. This is Tom’s second tenure with Sigma-Aldrich, having spent 13 years as Quality Systems Manager from 1986 to 1999, beginning as a Production Chemist and ending as Manager of Quality Assurance.

Tom’s wealth of knowledge and experience that is helping SAFC build upon its industry-leading regulatory compliance position. His current focus is on helping support risk mitigation, quality assurance and regulatory initiatives across SAFC’s product and service lines to enhance regulatory partnerships with customers to guide them through the challenges faced in procuring materials with the proper compliance profiles. Tom is also a founding board member of Rx360.

In addition to his in-depth knowledge of quality systems and the regulatory environment, Tom has experience in petrochemical chemistry, research biology, cell culture and purchasing, and received graduate and Masters degrees from Illinois State University, majoring in Biology with a minor in Chemistry. 

David McCarthy
Pfizer
Senior Director
Worldwide Procurement

Dave McCarthy began his career in 1984 as a Project Engineer with the Colgate-Palmolive Company at the Jersey City, NJ manufacturing plant; Colgate’s original site.  As the plant eventually closed three years later due to its valuable proximity to Manhattan, he was hired in 1987 by RJR Nabisco World Headquarters as a Process Engineer for food manufacturing where he learned and applied statistical problem solving and designed and implemented manufacturing processes for food products.  

He was later rehired by Colgate-Palmolive in 1993 as part of the Mennen Acquisition as a Technical Associate. He received a U.S. process patent for continuous Clear Anti-Perspirant manufacturing in 1996.  From 1997 – 1998, he managed U.S. Contract Manufacturing Operations.

Dave joined Warner-Lambert in 1998 as Manager, Strategic Analysis as part of Consumer Sector Operations.  The company was acquired by Pfizer in 2001.  He joined Pfizer PGM Procurement in 2001 and has since managed multiple categories including direct and indirect materials & services as well as logistics.  At present, Dave holds the position of Senior Director, Worldwide Procurement and is responsible for Logistics as well as Sustainability. 

Dave is a graduate of Rutgers University and holds a BS in Chemical Engineering, a BA Business and an MBA in Finance.
 

Tony Wiederhold
Eli Lilly and Company
Consultant 
Global Procurement   

Tony Wiederhold is responsible at Lilly for sourcing of small-molecule API Starting Materials, Intermediates, and APIs for programs that are in clinical Phase 2 development through the legacy phase.                                                                                                                     

This includes establishing secure supply chains while programs are in development and managing Lilly’s network of small-molecule suppliers and cusTony manufacturers.  Tony has been with Lilly since 2004.

Tony received his Master of Science in Chemistry from Indiana University in 2004 and undergraduate degrees in 2000, also from Indiana University.

William Reis
Amgen
Vice President
Global Strategic Sourcing

William Reis joined Amgen as vice president of Global Strategic Sourcing in August 2012. In this role, he leads the development and implementation of Amgen’s Procurement programs and ensures strong support to the business in productivity, quality, supplier management and risk.

Reis joined Amgen from Cott Corporation, where he served as a member of the Executive senior leadership team, and as Chief Procurement Officer and senior vice president.  He was responsible for various functions in addition to the Procurement area including Board of Directors meetings participant. Most recently he led a major integration of a newly acquired major company.

With 20 years of experience in the procurement field, including 13 years with the Coca-Cola Company in various purchasing and procurement roles in the United States, Europe and Latin America, Reis also served as senior vice president and Chief Procurement Officer with Revlon, and vice president of Global Procurement Management of Goldman Sachs.

Reis received a Bachelor of Science degree in Law/Criminal Justice from St. John’s University, New York, and an MBA from Nova University, Florida.

Moderator

Scott Watson
AMPAC Fine Chemicals
Executive Director
Sales and Marketing

Scott Watson has more than 25 years experience in operations, business development, sales and mergers and acquisitions. 

He is currently Executive Director, Sales and Marketing at AMPAC Fine Chemicals, Rancho Cordova, CA, a leading manufacturer of active pharmaceutical ingredients for the pharmaceutical and biotechnology industries.

Prior to AMPAC, Scott held sales and operational leadership positions with Southern BioSystems, Durect Corporation, DSM, and APTUIT. In addition, Scott spent 5 years working with a Private Equity firm doing leveraged transactions.
A 1983 graduate of the US Naval Academy, Scott developed his leadership skills serving as an officer aboard a US submarine. He earned his MBA from George Mason University, Fairfax, VA and is a Chartered Financial Analyst (CFA).